K2M settles acquisition lawsuit with Stryker: 5 things to know

Spinal Tech

After filing updated financial figures with the Security and Exchange Commission, K2M settled its ongoing litigation with Stryker.

Here are five things to know:

1. K2M filed to halt Stryker's $1.4 billion acquisition of the company, stating the deal did not disclose correct financial values.

2. On Oct. 22, K2M mollified the investors who filed the lawsuit to block the acquisition through the release of detailed financial projections and statements.

3. In the settlement, K2M stated it "believes that the actions are without merit and that no further disclosure is required."

4. K2M shareholders are expected to vote on the acquisition Nov. 7 after Stryker pushed the deadline to Nov. 16.

5. Stryker will pay $27.50 per share, a 27 percent premium on K2M's closing price that ended Aug. 29.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers